FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2114408384> ?p ?o ?g. }

• W2114408384 endingPage "879" @default.
• W2114408384 startingPage "874" @default.
• W2114408384 abstract "This study describes the antileishmanial efficacy of the novel drug formulation of amphotericin B (AmB) attached to functionalized carbon nanotubes (f-CNTs) and compares it with AmB. f-CNTs were prepared in a two-step chemical carboxylation and amidation process. The AmB was then attached to make f-CNT–AmB and its construction was confirmed by Fourier transform infrared (FTIR) spectroscopy and transmission electron microscopy (TEM). The cytotoxicity of the constructed compound, f-CNT–AmB, was assessed in vitro using the J774A.1 macrophage cell line and in vivo using healthy BALB/c mice. Antileishmanial activity of AmB and f-CNT–AmB was assessed in vitro using a macrophage (J774A.1 cell line) model of Leishmania donovani infection. Antileishmanial activity was assessed in vivo by comparing the parasite load of hamsters treated with a 5 day course of AmB, f-CNTs or f-CNT–AmB initiated at 30 days after infection with L. donovani parasites. The FTIR spectroscopy and TEM data demonstrate the successful attachment of AmB to f-CNTs. The in vitro cytotoxicity of AmB, f-CNTs and f-CNT–AmB was measured by the cytotoxic concentration required to kill 50% of the cells: 0.48 ± 0.06 μg/mL; 7.31 ± 1.16 μg/mL; 0.66 ± 0.17 μg/mL, respectively, in the J774A.1 cell line. The in vivo toxicity assessment of the compounds in BALB/c mice revealed no hepatic or renal toxicity. Against intracellular amastigotes the in vitro antileishmanial efficacy of f-CNT–AmB was significantly higher than that of AmB (IC50 0.00234 ± 0.00075 μg/mL versus 0.03263 ± 0.00123 μg/mL; P ≤ 0.0001). The percentage inhibition of amastigote replication in hamsters treated with f-CNT–AmB was significantly more than that with AmB (89.85% ± 2.93% versus 68.97% ± 1.84%; P = 0.0004). The results of these experiments clearly demonstrate that f-CNT–AmB has significantly greater antileishmanial efficacy than AmB and had no significant cytotoxic effects." @default.
• W2114408384 created "2016-06-24" @default.
• W2114408384 creator A5005151809 @default.
• W2114408384 creator A5020425587 @default.
• W2114408384 creator A5037204665 @default.
• W2114408384 creator A5064045942 @default.
• W2114408384 creator A5082967515 @default.
• W2114408384 creator A5083008310 @default.
• W2114408384 creator A5085370944 @default.
• W2114408384 date "2011-02-03" @default.
• W2114408384 modified "2023-10-16" @default.
• W2114408384 title "Targeted killing of Leishmania donovani in vivo and in vitro with amphotericin B attached to functionalized carbon nanotubes" @default.
• W2114408384 cites W1964307459 @default.
• W2114408384 cites W1965680705 @default.
• W2114408384 cites W1975716763 @default.
• W2114408384 cites W1997612513 @default.
• W2114408384 cites W2001990028 @default.
• W2114408384 cites W2013470095 @default.
• W2114408384 cites W2021048158 @default.
• W2114408384 cites W2035531193 @default.
• W2114408384 cites W2043933297 @default.
• W2114408384 cites W2072339916 @default.
• W2114408384 cites W2072809427 @default.
• W2114408384 cites W2082293404 @default.
• W2114408384 cites W2145947441 @default.
• W2114408384 cites W2152252380 @default.
• W2114408384 cites W2159638843 @default.
• W2114408384 cites W2162459979 @default.
• W2114408384 cites W2329029165 @default.
• W2114408384 doi "https://doi.org/10.1093/jac/dkr002" @default.
• W2114408384 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3307040" @default.
• W2114408384 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21393222" @default.
• W2114408384 hasPublicationYear "2011" @default.
• W2114408384 type Work @default.
• W2114408384 sameAs 2114408384 @default.
• W2114408384 citedByCount "130" @default.
• W2114408384 countsByYear W21144083842012 @default.
• W2114408384 countsByYear W21144083842013 @default.
• W2114408384 countsByYear W21144083842014 @default.
• W2114408384 countsByYear W21144083842015 @default.
• W2114408384 countsByYear W21144083842016 @default.
• W2114408384 countsByYear W21144083842017 @default.
• W2114408384 countsByYear W21144083842018 @default.
• W2114408384 countsByYear W21144083842019 @default.
• W2114408384 countsByYear W21144083842020 @default.
• W2114408384 countsByYear W21144083842021 @default.
• W2114408384 countsByYear W21144083842022 @default.
• W2114408384 countsByYear W21144083842023 @default.
• W2114408384 crossrefType "journal-article" @default.
• W2114408384 hasAuthorship W2114408384A5005151809 @default.
• W2114408384 hasAuthorship W2114408384A5020425587 @default.
• W2114408384 hasAuthorship W2114408384A5037204665 @default.
• W2114408384 hasAuthorship W2114408384A5064045942 @default.
• W2114408384 hasAuthorship W2114408384A5082967515 @default.
• W2114408384 hasAuthorship W2114408384A5083008310 @default.
• W2114408384 hasAuthorship W2114408384A5085370944 @default.
• W2114408384 hasBestOaLocation W21144083841 @default.
• W2114408384 hasConcept C109316439 @default.
• W2114408384 hasConcept C127413603 @default.
• W2114408384 hasConcept C136764020 @default.
• W2114408384 hasConcept C13965031 @default.
• W2114408384 hasConcept C150903083 @default.
• W2114408384 hasConcept C160892712 @default.
• W2114408384 hasConcept C185592680 @default.
• W2114408384 hasConcept C192562407 @default.
• W2114408384 hasConcept C202751555 @default.
• W2114408384 hasConcept C203014093 @default.
• W2114408384 hasConcept C207001950 @default.
• W2114408384 hasConcept C2776555147 @default.
• W2114408384 hasConcept C2778689377 @default.
• W2114408384 hasConcept C2779548794 @default.
• W2114408384 hasConcept C2779629538 @default.
• W2114408384 hasConcept C2781092759 @default.
• W2114408384 hasConcept C2781333301 @default.
• W2114408384 hasConcept C41008148 @default.
• W2114408384 hasConcept C42360764 @default.
• W2114408384 hasConcept C54355233 @default.
• W2114408384 hasConcept C55493867 @default.
• W2114408384 hasConcept C71928629 @default.
• W2114408384 hasConcept C81885089 @default.
• W2114408384 hasConcept C86803240 @default.
• W2114408384 hasConcept C89423630 @default.
• W2114408384 hasConcept C98274493 @default.
• W2114408384 hasConcept C98319499 @default.
• W2114408384 hasConceptScore W2114408384C109316439 @default.
• W2114408384 hasConceptScore W2114408384C127413603 @default.
• W2114408384 hasConceptScore W2114408384C136764020 @default.
• W2114408384 hasConceptScore W2114408384C13965031 @default.
• W2114408384 hasConceptScore W2114408384C150903083 @default.
• W2114408384 hasConceptScore W2114408384C160892712 @default.
• W2114408384 hasConceptScore W2114408384C185592680 @default.
• W2114408384 hasConceptScore W2114408384C192562407 @default.
• W2114408384 hasConceptScore W2114408384C202751555 @default.
• W2114408384 hasConceptScore W2114408384C203014093 @default.
• W2114408384 hasConceptScore W2114408384C207001950 @default.
• W2114408384 hasConceptScore W2114408384C2776555147 @default.
• W2114408384 hasConceptScore W2114408384C2778689377 @default.
• W2114408384 hasConceptScore W2114408384C2779548794 @default.

• next